Lipomatosis: Clinical Trials

30 trials for Lipomatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 5 recruiting, 5 terminated, 3 unknown. 13 Phase 2, 4 Not applicable, 4 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 213Completed 9, Active not recruiting 2, Terminated 1, Unknown 1
Not applicable4Terminated 2, Completed 1, Recruiting 1
Phase 14Active not recruiting 1, Completed 1, Terminated 1, Unknown 1
Phase 34Completed 2, Recruiting 1, Unknown 1

Follow Lipomatosis: new trials by email Literature Review of Lipomatosis trials Research Report on Lipomatosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease Lipomas
CBL-514 injection, 0.9% Sodium chloride - Dercum's Disease
Phase 2CompletedCaliway Biopharmaceuticals Co., Ltd.192024-11-272026-09-22
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Mavorixafor, Placebo - Neutropenia
Phase 3RecruitingX4 Pharmaceuticals1762024-06-062026-08-06
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
Shwachman-Diamond Syndrome, SDS
RecruitingShwachman-Diamond Syndrome Alliance Inc80002024-02-072025-05-31
Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)
Metreleptin - Lipomatosis, Multiple Symmetrical
Phase 2Active not recruitingUniversity of Michigan42023-08-012025-06-12
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas
10 mg CBL-514 per injection, 15 mg CBL-514 per injection - Dercum's Disease
Phase 2CompletedCaliway Biopharmaceuticals Co., Ltd.122022-10-032023-04-20
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Treosulfan, Fludarabine Phosphate, Tacrolimus - Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia
Phase 2CompletedFred Hutchinson Cancer Center402022-04-192026-03-09
Prospective Study on the Consequences of Weight Loss After Bariatric Surgery on Obese Patients' Spine.
Full Spine Radiography, Lumbar spine MRI - Low Back Pain in Obese Patients After Important Weight Loss
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris802021-06-032025-09-15
Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study
Hydrocortisone, Placebo - Symmetric Lipomatoses, Multiple
Phase 3UnknownErasmus Medical Center12021-06-012021-03-29
Examining the Effects of Dorsal Column Stimulation on Pain From Lumbar Spinal Stenosis Related to Epidural Lipomatosis.
Spinal Cord Stimulator - Lipomatosis, Low Back Pain
CompletedUniversity Hospitals Cleveland Medical Center32020-09-222026-02-03
Diabetes/ Endocrine Surveillance in SDS
Oral Glucose Tolerance Test, Modified Oral Glucose Tolerance Test, Modified Mixed Meal Tolerance Test - Shwachman-Diamond Syndrome
TerminatedWashington University School of Medicine112020-01-102024-08-19
Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's Disease
RZL-012 - Lipedema, Dercum Disease
Phase 2CompletedRaziel Therapeutics Ltd.122018-06-282024-02-08
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Cyclophosphamide, Fludarabine Phosphate, Laboratory Biomarker Analysis - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission
Phase 2TerminatedRoswell Park Cancer Institute312017-12-072025-07-04
Insight Into Subcutaneous Adipose Tissue Disorders
Lipedema, Dercum's Disease
UnknownUniversity of Arizona5002016-06-012017-09-15
Shwachman Diamond Syndrome Registry and Study
Shwachman-Diamond Syndrome, Shwachman-Diamond Syndrome-Like
RecruitingBoston Children's Hospital50002016-01-192026-04-06
Determination of the Postprandial Responses to Two Cereal Foods Differing by Their SDS Content Consumed Alone.
Sandwich biscuit high in SDS, Co-extruded cereal low in SDS - Metabolic Disorder; Carbohydrate, Absorption, Intestine
Not applicableCompletedMondelēz International, Inc.202015-09-012017-09-14
Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
BPX-501 and Rimiducid - Primary Immune Deficiency Disorders, Hemophagocytic Lymphohistiocytosis
Phase 1TerminatedBellicum Pharmaceuticals12015-02-012024-03-25
Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies
Reduced Toxicity Ablative Regimen, Reduced Intensity Preparative Regimen, Myeloablative Preparative Regimen - Sickle Cell Disease, Transfusion Dependent Alpha- or Beta- Thalassemia
Not applicableTerminatedMasonic Cancer Center, University of Minnesota382014-09-022025-03-03
Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
Abatacept - Hurler Syndrome, Fanconi Anemia
Phase 1CompletedEmory University102014-01-012019-12-26
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
CliniMACS CD34+ Reagent System, Thiotepa, Cyclophosphamide - Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML)
Phase 1 / Phase 2UnknownDiane George142013-06-032024-06-04

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Shwachman-Diamond Syndrome (21)  ·  Anemia, Diamond-Blackfan (14)  ·  Neutropenia, Severe Congenital, Autosomal Recessive 3 (11)  ·  Anemia, Sickle Cell (10)  ·  Anemia, Aplastic (9)  ·  Dyskeratosis Congenita (7)  ·  Fanconi Anemia (7)  ·  Bone Marrow Failure Disorders (6)  ·  Lymphohistiocytosis, Hemophagocytic (6)  ·  Wiskott-Aldrich Syndrome (6)  ·  Adiposis Dolorosa (5)  ·  Granulomatous Disease, Chronic (5)  ·  Lipedema (5)  ·  Primary Immunodeficiency Diseases (5)  ·  Thalassemia (5)

Broader conditions

Nutritional and Metabolic Diseases (30)  ·  Lipid Metabolism Disorders (28)  ·  Metabolic Diseases (26)  ·  Hemic and Lymphatic Diseases (22)  ·  Bone Marrow Diseases (21)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (21)  ·  Digestive System Diseases (21)  ·  Lipid Metabolism, Inborn Errors (21)  ·  Pancreatic Diseases (21)  ·  Hematologic Diseases (20)  ·  Exocrine Pancreatic Insufficiency (19)  ·  Genetic Diseases, Inborn (19)  ·  Congenital Bone Marrow Failure Syndromes (17)  ·  Skin and Connective Tissue Diseases (17)

Interventions

fludarabine phosphate (7)  ·  Antilymphocyte Serum (4)  ·  Peripheral Blood Stem Cell Transplantation (4)  ·  Tacrolimus (4)  ·  Whole-Body Irradiation (4)  ·  Busulfan (3)  ·  Cyclophosphamide (3)  ·  Methotrexate (3)  ·  Alemtuzumab (2)  ·  Bone Marrow Transplantation (2)  ·  Melphalan (2)  ·  Mycophenolic Acid (2)  ·  fludarabine (2)  ·  merphos (2)  ·  thymoglobulin (2)

Sponsors

Masonic Cancer Center, University of Minnesota (3)  ·  Caliway Biopharmaceuticals Co., Ltd. (2)  ·  Diane George (2)  ·  Emory University (2)  ·  Fred Hutchinson Cancer Center (2)  ·  Roswell Park Cancer Institute (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bellicum Pharmaceuticals (1)  ·  Boston Children's Hospital (1)  ·  Centre Hospitalier Universitaire de Liege (1)  ·  Erasmus Medical Center (1)  ·  Mondelēz International, Inc. (1)  ·  National Cancer Institute (NCI) (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Raziel Therapeutics Ltd. (1)

Countries

United States (24)  ·  Belgium (3)  ·  Australia (2)  ·  Czechia (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Spain (2)  ·  Switzerland (2)  ·  Argentina (1)  ·  Austria (1)  ·  Canada (1)  ·  Colombia (1)  ·  Denmark (1)

Top investigators

Diane George, MD (2)  ·  Angela Smith, MD (1)  ·  Anne Sheu (1)  ·  Ashish Gupta, MBBS, MPH (1)  ·  David A. Williams (1)  ·  Elif Oral (1)  ·  Eva M Sevick, PhD (1)  ·  Garry Tobin, MD (1)  ·  George Chen (1)  ·  Jennie Brand Miller (1)  ·  John Horan, MD (1)  ·  John T Horan, MD (1)  ·  Karen L Herbst, PhD, MD (1)

Results publications

PMID 24786393, PMID 25304614, PMID 25405500, PMID 25425683, PMID 25963299, PMID 26095669, PMID 28280134, PMID 28623992, PMID 31836590, PMID 32790018, PMID 33786515, PMID 33810313, PMID 34162668, PMID 34852175, PMID 35322185, PMID 35360980, PMID 37354000, PMID 39279436, PMID 40097137, PMID 40762130

NIH funding

2023 (1), P30CA015704 (1), R01CA128919 (1), R01HL092923 (1), U10HL069294 (1)